After my previous adventures with Reticula (which you can read all about here) I kind of gave up on pitching it for infectious disease diagnostics. I’m still confident that meta-genomic sequencing wins out over over qPCR in terms of its ability to detect and contain future viral outbreaks (and can be cost competitive,
“ However I’m less confident that it’s possible for me to get such a project funded in the short term.”
Can you share what led you to this conclusion?